triclosan
Approved
Jul 11, 1997
Triclosan was used as a hospital scrub in the 1970s. Since then, it has expanded commercially and is now prevalent in soaps (0.10-1.00%), shampoos, deodorants, toothpastes, mouth washes, cleaning supplies and pesticides. It is part of consumer products, including kitchen utensils, toys, bedding, socks and trash bags. In healthcare, triclosan is used in surgical scrubs and hand washes. Use in surgical units is effective with a minimum contact time of approximately two minutes. More recently, showering with 2% triclosan has become a recommended regimen in surgical units for the decolonization of patients whose skin carries methicillin-resistant Staphylococcus aureus (MRSA). Triclosan is also used in the coatings for some surgical sutures. Triclosan has been employed as a selective agent in molecular cloning. At high concentrations, triclosan acts as a biocide with multiple cytoplasmic and membrane targets. However, at the lower concentrations seen in commercial products, triclosan appears bacteriostatic, and it targets bacteria primarily by inhibiting fatty acid synthesis. Triclosan binds to bacterial enoyl-acyl carrier protein reductase (ENR) enzyme, which is encoded by the gene FabI. This binding increases the enzyme's affinity for nicotinamide adenine dinucleotide (NAD+). This results in the formation of a stable, ternary complex of ENR-NAD+-triclosan, which is unable to participate in fatty acid synthesis. Fatty acids are necessary for building and reproducing cell membranes. Humans do not have an ENR enzyme and thus are not affected. — NCATS
Clinical trial activity
44 trials · 24 clinical orgs · 1 marketing orgs
Earliest trial started Nov 1, 2000 (NCT00763165)
Timeline
1990s
- Jul 11, 1997
Colgate Palmolive — Earliest FDA Approval
- Jul 11, 1997
Colgate Palmolive — NDA Secondary Org
- Jul 11, 1997
Colgate Palmolive — NDA Organization
2000s
- Jan 1, 2000
Colgate Palmolive — Earliest Phase 3 Sponsor(trial)
- Jan 1, 2007
Colgate Palmolive — Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Studied for
- Antisepsis · Phase 4
- Bacterial Infections · Phase 3
- Cesarean Section · Phase 4
- Coronary Artery Bypass · Phase 4
- Dental Plaque · Phase 4
- Dentin Sensitivity · Phase 3
- Diabetes Mellitus, Type 2 · Phase 4
- Gingival Diseases · Phase 3
- Gingivitis · Phase 4
- Inflammation · Phase 4
- Laparoscopy · Phase 4
- Mouth · Phase 4
- Mucositis · Phase 3
- Peri-Implantitis · Phase 3
- Periodontal Diseases · Phase 4
- Periodontitis · Phase 4
- Saliva · Phase 3
- Surgical Wound · Phase 4
- Surgical Wound Infection · Phase 4
Mechanism of action
FABI antagonist
Combination products
colgate total
Approval history
- approvedJul 11, 1997
Chemistry & pharmacology
SMILES
OC1=CC(Cl)=CC=C1OC2=CC=C(Cl)C=C2Cl- Mol. weight
- 289.542 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Discontinued
Oral
No
Parenteral
No
Topical
Yes
Sources
- WikipediaTriclosan ↗
- NCATS4NM5039Y5X ↗
- ChEMBLCHEMBL849 ↗
Also known as
- 2,4,4'-trichloro-2'-hydroxydiphenyl ether
- 2,4,4'-trichloro-2'-hydroxydiphenyl ether
- 5-chloro-2-(2,4-dichloro-phenoxy)-phenol
- 5-chloro-2-(2,4-dichloro-phenoxy)-phenol
- aquasept
- aquasept
- innoxa
- manusept
- manusept
- skinsan
- stri-dex cleansing bar
- stri-dex cleansing bar
- stri-dex face wash
- stri-dex face wash
- tegusept
- triclosan
- triclosan
- triclosan
- triclosan
- triclosan
- triclosan
- triclosan
- triclosan
- triclosanum
- triclosanum
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05330650 | Phase 4 | Nov 1, 2020 | Ben Arous Hospital, Tunis, Tunisia, Tunis University |
| NCT04538365 | Phase 4 | Oct 1, 2020 | Centro Ortopedico y Quirurgico del Pie, Universidad Complutense de Madrid |
| NCT04256824 | Phase 4 | Feb 10, 2020 | Al Safwa Hospital, Al Zohour Hospital, ClinAmygate, Minia University, Misr University for Science and Technology, MSKMC Univeristy Hospital |
| NCT04255927 | Phase 4 | Feb 8, 2020 | Al Safwa Hospital, Cairo University, ClinAmygate, Misr University for Science and Technology |
| NCT03659344 | N/A | Sep 1, 2016 | Shahid Beheshti University of Medical Sciences, Shiraz University |
| NCT03642353 | Phase 4 | Jan 30, 2016 | University of Campinas |
| NCT02670135 | Phase 4 | Jun 1, 2015 | Colgate Palmolive |
| NCT02193165 | Phase 3 | Jul 1, 2014 | Colgate Palmolive |
| NCT02360995 | Phase 4 | Jun 1, 2014 | Colgate Palmolive, Loma Linda University |
| NCT02366689 | Phase 4 | Jun 1, 2014 | Colgate Palmolive |
| NCT02194621 | Phase 4 | Jan 1, 2014 | Colgate Palmolive |
| NCT03241407 | N/A | Jul 1, 2013 | Sao Paulo State University |
| NCT03145610 | N/A | Jun 1, 2013 | Sao Paulo State University |
| NCT01799226 | N/A | Mar 31, 2013 | University of Michigan |
| NCT01457859 | Phase 4 | Oct 1, 2011 | Technion University |
| NCT01220700 | N/A | Sep 30, 2010 | University of Oulu |
| NCT03191721 | Phase 3 | Jun 30, 2010 | Colgate Palmolive, Universidade Estadual de Maringá, University of Guarulhos (UNG) |
| NCT01019447 | Phase 4 | Nov 30, 2009 | Cairo University |
| NCT00762528 | Phase 4 | Feb 1, 2009 | Colgate Palmolive |
| NCT00763269 | Phase 3 | Sep 1, 2008 | Colgate Palmolive, University of Puerto Rico |
Organizations
Research & Development (24)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Colgate Palmolive | For profit | 32 | 31 | 3 | 2000 |
| Al Safwa Hospital | Academic/Hospital | 2 | 0 | 1 | 2020 |
| Cairo University | Academic/Hospital | 2 | 1 | 1 | 2009 |
| ClinAmygate | For profit | 2 | 2 | 1 | 2020 |
| Misr University for Science and Technology | Academic/Hospital | 2 | 0 | 1 | 2020 |
| Sao Paulo State University | Academic/Hospital | 2 | 2 | 1 | 2013 |
| University of Otago | Academic/Hospital | 2 | 0 | 1 | 2006 |
| Al Zohour Hospital | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Ben Arous Hospital, Tunis, Tunisia | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Centro Ortopedico y Quirurgico del Pie | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Loma Linda University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Minia University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| MSKMC Univeristy Hospital | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Shahid Beheshti University of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Shiraz University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Technion University | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Tunis University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Universidad Complutense de Madrid | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Universidade Estadual de Maringá | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Campinas | Academic/Hospital | 1 | 1 | 1 | 2016 |
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Colgate Palmolive | For profit | NDA2 | Jul 11, 1997 |
| Colgate Palmolive | For profit | NDA | Jul 11, 1997 |